Royalty Pharma RPRX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$22.60M (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 32.9% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 2.61% to 2.94% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| EFG Bank AG | Private Company | 2026/Q4 | +3,935,402 | 0.9% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q4 | +3,518,480 | 3.3% |
| Invesco Ltd. | Mutual Fund | 2026/Q4 | +2,987,686 | 1.4% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q4 | +2,632,410 | 1.4% |
| UBS Asset Management | Mutual Fund | 2026/Q4 | +2,561,101 | 1.3% |
| Deka Investment GmbH | Mutual Fund | 2026/Q4 | +1,921,417 | 0.6% |
| Nordea Investment Management AB | Mutual Fund | 2026/Q4 | +1,864,931 | 1.0% |
| Royal London Asset Management Ltd. | Mutual Fund | 2026/Q4 | +1,654,110 | 1.3% |
| BlackRock | Mutual Fund | 2026/Q4 | +1,284,419 | 6.5% |
| Managed Account Advisors LLC | Mutual Fund | 2026/Q4 | +1,036,855 | 0.6% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q4 | +1,016,707 | 0.3% |
| Franklin Resources | Mutual Fund | 2026/Q4 | +975,048 | 0.6% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q4 | +938,028 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q4 | +885,635 | 1.8% |
| Allianz Asset Management AG | Mutual Fund | 2026/Q4 | +799,263 | 0.2% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 5 Nov 2026 | Marshall Urist | Head of Research & Investments | Derivative Exercise and Retained | +150,000 | – | 174,361 |
| 5 Nov 2026 | Terrance Coyne | Chief Financial Officer | Other Acquisition | +7,122 | – | 307,512 |
| 5 Nov 2026 | Terrance Coyne | Chief Financial Officer | Derivative Exercise and Retained | +250,000 | – | 307,512 |
| 3 Nov 2026 | Christopher Hite | Chairman of Partnering & Investments | Other Acquisition | +7,122 | – | 300,723 |
| 3 Nov 2026 | Marshall Urist | Head of Research & Investments | Other Acquisition | +5,341 | – | 174,361 |
| 3 Nov 2026 | Pablo Legorreta | Founder, Chairman of the Board & CEO | Other Acquisition | +42,209 | – | 4,954,404 |
| 4 Oct 2026 | Marshall Urist | Head of Research & Investments | Automatic Disposition | -4,126 | $57.10 | 19,020 |
| 29 Sep 2026 | Bonnie Bassler | Independent Director | Other Acquisition | +642 | $58.41 | 75,278 |
| 27 Sep 2026 | Marshall Urist | Head of Research & Investments | Automatic Disposition | -4,126 | $57.88 | 23,146 |
| 21 Sep 2026 | Christopher Hite | Chairman of Partnering & Investments | Automatic Disposition | -100,000 | $58.93 | 293,601 |
| 18 Aug 2026 | Christopher Hite | Chairman of Partnering & Investments | Other Disposition | -16,800 | – | 393,601 |
| 17 Aug 2026 | Christopher Hite | Chairman of Partnering & Investments | Automatic Disposition | -100,000 | $59.97 | 393,601 |
| 12 Aug 2026 | Terrance Coyne | Chief Financial Officer | Automatic Disposition | -11,002 | $59.14 | 50,390 |
| 6 Aug 2026 | Marshall Urist | Head of Research & Investments | Other Derivative Disposition | -3,000 | – | 244,412 |
| 6 Aug 2026 | Terrance Coyne | Chief Financial Officer | Other Disposition | -18,500 | – | – |
| 6 Aug 2026 | Pablo Legorreta | Founder, Chairman of the Board & CEO | Other Derivative Disposition | -30,000 | – | 662,701 |
| 4 Aug 2026 | Christopher Hite | Chairman of Partnering & Investments | Other Acquisition | +11,002 | – | 510,401 |
| 4 Aug 2026 | Marshall Urist | Head of Research & Investments | Other Acquisition | +8,252 | – | 27,272 |
| 4 Aug 2026 | Terrance Coyne | Chief Financial Officer | Other Acquisition | +11,002 | – | 61,392 |
| 4 Aug 2026 | Pablo Legorreta | Founder, Chairman of the Board & CEO | Other Acquisition | +65,216 | – | 4,912,195 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 13,075,722 | 2.9% | 4.0 |
| 15 Oct 2026 | 12,843,101 | 2.9% | 4.3 |
| 30 Sep 2026 | 12,885,147 | 2.9% | 4.4 |
| 15 Sep 2026 | 11,647,565 | 2.6% | 3.3 |
| 31 Aug 2026 | 11,903,716 | 2.7% | 5.1 |
| 14 Aug 2026 | 11,606,728 | 2.6% | 3.8 |
No comments yet — be the first to weigh in on RPRX.
Sign in to join the discussion.